PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 91 filers reported holding PASSAGE BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,401,000 | -78.7% | 140,699 | -71.6% | 0.05% | -78.7% |
| Q2 2021 | $6,566,000 | -24.8% | 495,931 | -0.7% | 0.24% | -24.1% |
| Q1 2021 | $8,732,000 | +0.2% | 499,541 | +46.6% | 0.32% | +9.0% |
| Q4 2020 | $8,712,000 | +94.5% | 340,698 | -0.3% | 0.29% | +57.1% |
| Q3 2020 | $4,479,000 | -53.5% | 341,627 | -3.2% | 0.18% | -56.2% |
| Q2 2020 | $9,640,000 | +72.6% | 352,743 | -0.5% | 0.42% | +30.0% |
| Q1 2020 | $5,585,000 | – | 354,601 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,959,769 | $4,668,631 | 5.54% |
| New Leaf Venture Partners, L.L.C. | 2,497,922 | $2,348,047 | 2.02% |
| BML Capital Management, LLC | 2,058,767 | $1,937,917 | 1.74% |
| Lynx1 Capital Management LP | 1,167,343 | $1,098,820 | 0.72% |
| Acuitas Investments, LLC | 418,173 | $393,626 | 0.23% |
| Orbimed Advisors | 10,124,576 | $9,530,263 | 0.17% |
| Frazier Life Sciences Management, L.P. | 1,850,000 | $1,741,405 | 0.10% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $282,390 | 0.04% |
| Marquette Asset Management, LLC | 86,050 | $80,999 | 0.02% |
| Annandale Capital, LLC | 54,338 | $51 | 0.02% |